The Sinerga Research Centre in Italy has recently developed an innovative combination of extremely effective ingredients suitable for delivering a reduced amount of actives by keeping a high level of efficacy.
One of the most relevant uses of the development is for improved superficial blood flow in vessels with increased blood perfusion. This makes it suitable for treatments where modification of microcirculation is necessary, e.g. for cellulite and heavy legs.
The development can also be used to improve the control of moisturisation and protection of the epidermal barrier, restoring a damaged barrier by restructuring the intercellular lipid network and providing an immediately moisturising effect on the superficial stratum corneum. Characteristics make the development suitable for any treatment in which the recovery of the skin barrier is necessary, e.g. for atopic dermatitis, psoriasis and dry skin.
